首站-论文投稿智能助手
典型文献
Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin
文献摘要:
Vestibular schwannoma(VS),one of characteristic tumors of neurofibromatosis type 2(NF2),is an intracranial tumor that arises from Schwann cells of the vestibular nerve.VS results in hearing loss,tinnitus,dizziness,and even death,but there are currently no FDA-approved drugs for treatment.In this study,we established a high-throughput screening to discover effective compounds that could inhibit the viability of VS cells.Among 1019 natural products from the Korea Chemical Bank screened,we found that celastrol,a pentacyclic triterpene derived from a Tripterygium Wilfordi plant,exerted potent inhibitory effect on the viability of VS cells with an IC50 value of 0.5 μM.Celastrol(0.5,1 μM)dose-dependently inhibited the proliferation of primary VS cells derived from VS patients.Celastrol also inhibited the growth,and induced apoptosis of two other VS cell lines(HEI-193 and SC4).Aberrant activation of Wnt/β-catenin signaling has been found in VS isolated from clinically defined NF2 patients.In HEI-193 and SC4 cells,we demonstrated that celastrol(0.1,0.5 μM)dose-dependently inhibited TOPFlash reporter activity and protein expression of β-catenin,but not mRNA level of β-catenin.Furthermore,celastrol accelerated the degradation of β-catenin by promoting the formation of the β-catenin destruction complex.In nude mice bearing VS cell line SC4 allografts,administration of celastrol(1.25 mg·kg-1·d-1,i.p.once every 3 days for 2 weeks)significantly suppressed the tumor growth without showing toxicity.Collectively,this study demonstrates that celastrol can inhibit Wnt/β-catenin signaling by promoting the degradation of β-catenin,consequently inhibiting the growth of VS.
文献关键词:
作者姓名:
Na Hui Kim;Minji Kwon;Jiwoo Jung;Hyo Byeong Chae;Jiwoo Lee;Yeo-Jun Yoon;In Seok Moon;Ho K.Lee;Wan Namkung;Konstantina M.Stankovic;Se A.Lee;Jong Dae Lee;Sin-Aye Park
作者机构:
Department of ICT Environmental Health System,Graduate School,Soonchunhyang University,Asan-si 31538,Republic of Korea;Department of Biomedical Laboratory Science,College of Medical Sciences,Soonchunhyang University,Asan-si 31538,Republic of Korea;Department of Otorhinolaryngology,Yonsei University,College of Medicine,Seoul 03722,Republic of Korea;Colllege of Pharmacy and Yonsei Institute of Pharmaceutical Sciences,Yonsei University,Yeonsu-gu,Incheon 21983,Republic of Korea;Department of Otolaryngology-Head and Neck Surgery,Stanford University School of Medicine,Stanford,CA 94305,USA;Department of Otorhinolaryngology-Head and Neck Surgery,Soonchunhyang University Bucheon Hospital,Bucheon 14584,Republic of Korea
引用格式:
[1]Na Hui Kim;Minji Kwon;Jiwoo Jung;Hyo Byeong Chae;Jiwoo Lee;Yeo-Jun Yoon;In Seok Moon;Ho K.Lee;Wan Namkung;Konstantina M.Stankovic;Se A.Lee;Jong Dae Lee;Sin-Aye Park-.Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin)[J].中国药理学报(英文版),2022(11):2993-3001
A类:
pentacyclic,Wilfordi,TOPFlash
B类:
Celastrol,suppresses,growth,vestibular,schwannoma,mice,by,promoting,degradation,catenin,Vestibular,VS,one,characteristic,tumors,neurofibromatosis,type,NF2,intracranial,that,arises,from,Schwann,cells,nerve,results,hearing,loss,tinnitus,dizziness,even,death,but,there,are,currently,FDA,approved,drugs,treatment,In,this,study,established,high,throughput,screening,discover,effective,compounds,could,viability,Among,natural,products,Korea,Chemical,Bank,screened,found,celastrol,triterpene,derived,Tripterygium,plant,exerted,potent,inhibitory,IC50,value,dose,dependently,inhibited,proliferation,primary,patients,also,induced,apoptosis,two,other,lines,HEI,SC4,Aberrant,activation,Wnt,signaling,has,been,isolated,clinically,defined,demonstrated,reporter,activity,protein,expression,not,level,Furthermore,accelerated,formation,destruction,complex,nude,bearing,allografts,administration,once,every,days,weeks,significantly,suppressed,without,showing,toxicity,Collectively,demonstrates,consequently,inhibiting
AB值:
0.557189
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Potential medicinal plants involved in inhibiting 3CLpro activity:A practical alternate approach to combating COVID-19
Fan Yang;Xiao-lan Jiang;Akash Tariq;Sehrish Sadia;Zeeshan Ahmed;Jordi Sardans;Muhammad Aleem;Riaz Ullah;Rainer W.Bussmann-The Medical Center of General Practice,Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu 610041,Sichuan Province,China;Xinjiang Institute of Ecology and Geography,Chinese Academy of Sciences,Urumqi 830041,Xinjiang Uygur Autonomous Region,China;Department of Biological Sciences,University of Veterinary and Animal Sciences,Ravi Campus,Pattoki 55300,Pakistan;Consejo Superior de Investigaciones Científicas,Global Ecology Unit,Centre for Ecological Research and Forestry Applications-Consejo Superior de Investigaciones Cientificas-Universitat Autònoma de Barcelona,Bellaterra,Barcelona 08193,Catalonia,Spain;Centre for Ecological Research and Forestry Applications,Cerdanyola del Vallès 08193,Catalonia,Spain;Department of Pharmacognosy,College of Pharmacy,King Saud University,Riyadh 11451,Saudi Arabia;Department of Ethnobotany,Institute of Botany,Ilia State University,Tbilisi 0105,Georgia
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Eupalinolide B inhibits hepatic carcinoma by inducing ferroptosis and ROS-ER-JNK pathway
Yonghui Zhang;Haoyang Zhang;Jinage Mu;Meiyue Han;Zhihao Cao;Feng Dong;Tingting Wang;Lian Pan;Wujing Luo;Jiaxin Li;Huan Liu;Lishan Jin;Wenxuan Ding;Yong Wei;Xuesong Deng;Dan Liu;Xiuzhen He;Yi Pang;Xiao Mu;Zhongjun Wu;Dilong Chen-The First Affiliated Hospital of Chongqing Medical University,Chongqing 400042,China;The People's Hospital Affiliated to Chongqing Three Gorges Medical College,Chongqing 404100,China;Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area,Chongqing 404120,China;Chongqing Engineering Research Center of Antitumor Natural Drugs,Chongqing 404120,China;Key Laboratory of Intelligent Information Processing and Control,College of Electronic and Information Engineering,Chongqing Three Gorges University,Chongqing 404110,China
Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation
Qiubing Chen;Qian Li;Yuqi Liang;Menghang Zu;Nanxi Chen;Brandon S.B.Canup;Liyong Luo;Chenhui Wang;Liang Zeng;Bo Xiao-State Key Laboratory of Silkworm Genome Biology,College of Sericulture,Textile,and Biomass Sciences,Southwest University,Chongqing 400715,China;Chongqing Key Laboratory of Soft-Matter Material Chemistry and Function Manufacturing,School of Materials and Energy,Southwest University,Chongqing 400715,China;Department of Chemistry,Center for Diagnostics and Therapeutics,Georgia State University,Atlanta,GA 30303,USA;College of Food Science,Southwest University,Chongqing 400715,China;Chongqing Key Laboratory of Natural Product Synthesis and Drug Research,School of Pharmaceutical Sciences,Chongqing University,Chongqing 401331,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。